HALAVEN® (eribulin mesylate) Injection
Important Safety Information
|
Full Prescribing Information
|
Health Care Professionals
HALAVEN for another type of cancer
HALAVEN FOR ANOTHER TYPE OF CANCER >>

Scroll down for safety information

Is HALAVEN right for me? Can we talk about HALAVEN?: Discussion guide
'Is HALAVEN® Right for Me?
Metastatic Breast Cancer Community Groups HALAVEN® $0 Co-Pay Program HALAVEN® FAQs

Is HALAVEN® treatment for metastatic breast cancer right for me?

HALAVEN is a prescription medicine for adults with metastatic breast cancer (mBC) who have already received at least 2 other types of anticancer medicines for their breast cancer once it has spread to other parts of the body. Previous therapy should have included an anthracycline and a taxane for either early or advanced breast cancer.

When used alone after 2 prior chemotherapies for mBC, HALAVEN is the only chemotherapy that has been proven in a clinical trial to help some women live longer. Although some women lived longer and some women did not live as long, women who were treated with HALAVEN in a clinical trial lived an average of 13.2 months compared with women treated with other chemotherapy or hormone therapy, who lived an average of 10.6 months.

HALAVEN was studied in women with all types of tumor receptors. This means that their ER/PR hormone receptors (estrogen/progesterone receptors) were either positive or negative and their HER2 receptors (human epidermal growth factor receptor 2) were either positive or negative.

Find out more about HALAVEN

HALAVEN efficacy

HALAVEN safety

The HALAVEN treatment cycle


How do you know if HALAVEN is right for you, at this point in your treatment plan?

It's a decision that only you and your health care team can make. That decision will depend on a discussion that might include

  • your diagnosis
  • your overall health
  • what treatments you've had before

Ask your health care provider, “Can we talk about HALAVEN?”

To help with the discussion, you can download the Can we talk about HALAVEN? discussion guide below, fill it out with your information, print it, and bring it with you to your next appointment.

Go to discussion guide

Who is HALAVEN® (eribulin mesylate) Injection for?

HALAVEN is a prescription medicine used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other types of anticancer medicines after the cancer has spread.

HALAVEN is a prescription medicine used to treat adults with liposarcoma that cannot be treated with surgery or that has spread to other parts of the body, and who have received treatment with a certain type of anticancer medicine.

What safety information do I need to know about HALAVEN?

HALAVEN can cause serious side effects, including

  • Low white blood cell count (neutropenia). This can lead to serious infections that could lead to death. Your health care provider will check your blood cell counts. Call your health care provider right away if you develop fever (temperature above 100.5°F), chills, cough, or burning or pain when you urinate, as any of these can be symptoms of infection
  • Numbness, tingling, or pain in your hands or feet (peripheral neuropathy). Peripheral neuropathy is common with HALAVEN and sometimes can be severe. Tell your health care provider if you have new or worsening symptoms of peripheral neuropathy
  • Your health care provider may delay or decrease your dose or stop treatment with HALAVEN if you have side effects

Before you receive HALAVEN, tell your health care provider about all of your medical conditions, including if you

  • have liver or kidney problems
  • have heart problems, including a problem called congenital long QT syndrome
  • have low potassium or low magnesium in your blood
  • are pregnant or plan to become pregnant. HALAVEN can harm your unborn baby. Tell your health care provider right away if you become pregnant or think you are pregnant during treatment with HALAVEN. Females who are able to become pregnant should use an effective form of birth control during treatment with HALAVEN and for at least 2 weeks after the final dose of HALAVEN and males should use an effective form of birth control when having sex with female partners who are able to become pregnant during treatment with HALAVEN and for 3½ months (14 weeks) after the final dose of HALAVEN
  • are breastfeeding or plan to breastfeed. It is not known if HALAVEN passes into your breast milk. Do not breastfeed during treatment with HALAVEN and for 2 weeks after the final dose of HALAVEN

Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of HALAVEN?

HALAVEN can cause changes in your heartbeat (called QT prolongation). This can cause irregular heartbeats. Your health care provider may do heart monitoring (electrocardiogram or ECG) or blood tests during your treatment with HALAVEN to check for heart problems.

The most common side effects of HALAVEN in adults with breast cancer include low white blood cell count (neutropenia), low red blood cell count (anemia), weakness or tiredness, hair loss (alopecia), nausea, and constipation.

The most common side effects of HALAVEN in adults with liposarcoma include tiredness, nausea, hair loss (alopecia), constipation, stomach pain, and fever.

Your health care provider will do blood tests before and during treatment while you are taking HALAVEN. The most common changes to blood tests in adults with liposarcoma include low white blood cell count (neutropenia) and decreased blood levels of potassium or calcium.

For more information about HALAVEN, please see full Prescribing Information.